Home/Pipeline/Praluent (alirocumab)

Praluent (alirocumab)

High cholesterol

ApprovedCommercial

Key Facts

Indication
High cholesterol
Phase
Approved
Status
Commercial
Company

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.

View full company profile

Other High cholesterol Drugs

DrugCompanyPhase
Crestor (rosuvastatin)AstraZenecaApproved